157 related articles for article (PubMed ID: 36119229)
1. COVID-19 vaccination: Is it a matter of concern?
Kushwaha P; Pundhir A; Gahlot A
J Family Med Prim Care; 2022 Jun; 11(6):2431-2436. PubMed ID: 36119229
[TBL] [Abstract][Full Text] [Related]
2. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
Chakraborty A; Reval N; Kamath L
Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
[TBL] [Abstract][Full Text] [Related]
3. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
Jose D; Dhupdale N; Cacodcar JA; Kamat U
Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
[TBL] [Abstract][Full Text] [Related]
4. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
5. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press.
Thorakkattil SA; Abdulsalim S; Karattuthodi MS; Unnikrishnan MK; Rashid M; Thunga G
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891223
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Adverse Events Following COVID-19 Vaccination: A Cross-sectional Study in Ibadan, Nigeria.
Alao MA; Ogunbosi BO; Ibrahim OR; Oladokun RE; Lagunju IA
Niger Med J; 2022; 63(3):248-258. PubMed ID: 38835530
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
Rahmat H; Leelavathi M; Wan Ismail WF
Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with intention for revaccination among patients with adverse events following immunization.
Muñoz CE; Pham-Huy A; Pernica JM; Boucher FD; De Serres G; Vaudry W; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Noya F; Halperin SA; Top KA;
Vaccine; 2023 Oct; 41(42):6239-6247. PubMed ID: 37666696
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
12. Vaccine hesitancy after taking the first dose of COVID-19 vaccine: A challenge for the COVID-19 vaccination program in India.
Bansal Y; Chand P; Bansal N; Singh P
J Family Med Prim Care; 2022 May; 11(5):2201-2206. PubMed ID: 35800545
[TBL] [Abstract][Full Text] [Related]
13. Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana.
Marfoh K; Samba A; Okyere E; Acheampong F; Owusu E; Darko DNA; Zakariah J; Mensa H; Aidoo E; Mohammed Y
BMJ Open; 2023 Jun; 13(6):e061643. PubMed ID: 37380201
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
Kamble B; Bashar MA; Mishra CP
Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
[TBL] [Abstract][Full Text] [Related]
15. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.
Muluneh AG; Merid MW; Gelaye KA; Tilahun SY; Teshager NW; Abereha AY; Sugamo KS; Yimer MA; Kassa GM
Infect Drug Resist; 2022; 15():2409-2416. PubMed ID: 35535029
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel.
Hidayat R; Mustika AP; Avisha F; Djuliannisaa Z; Winari DD; Putri RA; Lisman HM; Davin V; Widhani A; Aini MH; Rahmadani M; Istanti ND; Giantini A
Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746485
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study.
Velhal GD; Kamath YV; Agrawal AS; Vora DS; Dwivedi VR
Indian J Community Med; 2022; 47(4):613-617. PubMed ID: 36742958
[TBL] [Abstract][Full Text] [Related]
18. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.
Zeitoun A; Hallit S; Chehade S; Ibrahim A; Helali M; Allam C; Karam R
J Pharm Policy Pract; 2023 Feb; 16(1):24. PubMed ID: 36810279
[TBL] [Abstract][Full Text] [Related]
19. Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines.
Jhaj R; Chaudhary D; Shukla AK; Yadav J
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560545
[TBL] [Abstract][Full Text] [Related]
20. Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana.
Yamoah P; Mensah KB; Padayachee N; Bangalee V; Oosthuizen F
Hum Vaccin Immunother; 2023 Dec; 19(1):2199654. PubMed ID: 37127290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
